The GLP-1 Analogs Liraglutide and Semaglutide Reduce Atherosclerosis in ApoE−/− and LDLr−/− Mice by a Mechanism That Includes Inflammatory Pathways

[Display omitted] •The GLP-1RAs liraglutide and semaglutide reduce cardiovascular risk in type 2 diabetes patients.•In ApoE−/− mice and LDLr−/− mice, liraglutide and semaglutide treatment significantly attenuated plaque lesion development, in part independently of body weight and cholesterol lowerin...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	JACC. Basic to translational science Ročník 3; číslo 6; s. 844 - 857
Hlavní autoři:	Rakipovski, Günaj, Rolin, Bidda, Nøhr, Jane, Klewe, Ib, Frederiksen, Klaus S., Augustin, Robert, Hecksher-Sørensen, Jacob, Ingvorsen, Camilla, Polex-Wolf, Joseph, Knudsen, Lotte Bjerre
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States Elsevier Inc 01.12.2018 Elsevier
Témata:	atherosclerosis Cardiovascular diabetes GLP-1 inflammation obesity PRECLINICAL RESEARCH atherosclerosis CD163 GLP-1 IL RNA GLP NASH OPN TNF WD LPS IFN MMP inflammation LDL diabetes obesity TIMP cluster of differentiation 163 molecule ribonucleic acid nonalcoholic steatohepatitis tissue inhibitor of metalloproteinases glucagon-like peptide interleukin osteopontin interferon low-density lipoprotein tumor necrosis factor matrix metalloproteinase lipopolysaccharide Western diet IFN, interferon CD163, cluster of differentiation 163 molecule RNA, ribonucleic acid TNF, tumor necrosis factor OPN, osteopontin NASH, nonalcoholic steatohepatitis IL, interleukin LPS, lipopolysaccharide WD, Western diet TIMP, tissue inhibitor of metalloproteinases LDL, low-density lipoprotein MMP, matrix metalloproteinase GLP, glucagon-like peptide
ISSN:	2452-302X, 2452-302X
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!